CAPR vs KMB · $1.62B cap vs P/E 19, rev $8.35B
Capricor Therapeutics Inc (CAPR) versus Kimberly-Clark Corporation (KMB) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. CAPR currently screens at market cap $1.62B.
Latest reported KMB revenue for 2026-06-30 was $8.35B. Net income was $1.01B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
CAPR currently screens at market cap $1.62B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Not investment advice. Open the CAPR and KMB stock pages for the full models.
Not investment advice.